• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Cell Manipulation Core

    October 3, 2013 | eNews

    The mission of the Cell Manipulation Core Facility (CMCF) is to produce safe and effective cellular components for patients with cancer that are enrolled in novel therapeutic clinical research protocols

    Faces of Faith: Celebrating Cancer Survivorship


    Presented by Dana-Farber/Harvard Cancer Center, the Faces of Faith: Celebrating Cancer Survivorship exhibit was displayed throughout the month of June at the Erick Jean Center for the Arts in Dorchester

    DF/HCC Member Awarded Fellow of American Society of Clinical Oncology (FASCO) Award




    Stephen A
    Taking Cabazitaxel into Childhood Cancers

    Taxol (paclitaxel) and related taxane drugs are widely used chemotherapies against solid tumor types in adults

    Afatinib with Post-Operative Radiation in Head and Neck Cancer
    Visualizing the Birth of Cancer in Zebrafish

    Cancer behaves differently in living animals than it does in a dish, so designing animal models is integral to both basic and clinical research in the DF/HCC Cancer Genetics Program

    Cancer Genetics Broadens Its Quest

    A revolution in cancer began almost 50 years ago when Dana-Farber researcher Frederick Li, MD, proposed that genes can raise the risk of inheriting cancer

Displaying results 22 to 28 out of 207